Report cover image

Europe AI in Pathology Market Size, Share & Trends Analysis Report By Neural Network, By Application (Drug Discovery, Disease Diagnosis & Prognosis, Clinical Workflow, and Others), By End User, By Component, By Country and Growth Forecast, 2023 - 2030

Publisher Knowledge Based Value (KBV) Research
Published Jan 05, 2024
Length 140 Pages
SKU # KBV18413615

Description

Europe AI in Pathology Market Size, Share & Trends Analysis Report By Neural Network, By Application (Drug Discovery, Disease Diagnosis & Prognosis, Clinical Workflow, and Others), By End User, By Component, By Country and Growth Forecast, 2023 - 2030


The Europe AI in Pathology Market would witness market growth of 15.4% CAGR during the forecast period (2023-2030).

AI in pathology has accelerated the transition toward personalized medicine by enabling the identification of specific biomarkers associated with individual patient profiles. In order to identify unique biomarkers, machine learning algorithms can analyze diverse data sets, including genetic information, pathology images, and clinical records. This facilitates the development of targeted therapies, optimizing therapy plans based on an individual's genetic makeup and disease characteristics. The seamless integration of AI in pathology with electronic health records has streamlined data management and accessibility. This integration enhances the efficiency of healthcare systems by providing a comprehensive view of patient data and facilitating data-driven decision-making.

The integration of AI in pathology has synergized with telepathology, allowing pathologists to collaborate remotely for consultations and second opinions. AI algorithms can assist in rapidly analyzing pathology images, enabling timely and accurate diagnoses even in geographically dispersed locations. This trend has proven especially valuable in addressing healthcare disparities and improving access to pathology expertise in underserved regions. AI algorithms excel in image recognition and pattern detection, making them invaluable for diagnostic assistance in pathology.

Europe is working on establishing clear regulatory frameworks for the use of AI in healthcare. Well-defined guidelines promote AI technologies' responsible and ethical deployment, fostering confidence among healthcare providers and patients. Implementing telepathology, facilitated by AI, enables remote access to pathology services. Due to the aforementioned factors the market growth will drive in this region.

The Germany market dominated the Europe AI in Pathology Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,215.1 Thousands by 2030. The UK market is exhibiting a CAGR of 14.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 16.2% during (2023 - 2030).

Based on Neural Network, the market is segmented into Convolutional neural networks (CNNs), Generative adversarial networks (GANs), Recurrent neural networks (RNNs), and Others. Based on Application, the market is segmented into Drug Discovery, Disease Diagnosis & Prognosis, Clinical Workflow, and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Reference Laboratories, and Academic & Research Institutes. Based on Component, the market is segmented into Scanners, and Software. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Hologic, Inc., Visiopharm A/S, Paige AI, Inc., PathAI, Inc., Aiforia Technologies Plc, Indica Labs, Inc., Optrascan, Inc. (Optra Ventures, LLC), MindPeak GmbH.

Scope of the Study

Market Segments covered in the Report:

By Neural Network
  • Convolutional neural networks (CNNs)
  • Generative adversarial networks (GANs)
  • Recurrent neural networks (RNNs)
  • Others
By Application
  • Drug Discovery
  • Disease Diagnosis & Prognosis
  • Clinical Workflow
  • Others
By End User
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Reference Laboratories
  • Academic & Research Institutes
By Component
  • Scanners
  • Software
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Visiopharm A/S
  • Paige AI, Inc.
  • PathAI, Inc.
  • Aiforia Technologies Plc
  • Indica Labs, Inc.
  • Optrascan, Inc. (Optra Ventures, LLC)
  • MindPeak GmbH
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

140 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe AI in Pathology Market, by Neural Network
1.4.2 Europe AI in Pathology Market, by Application
1.4.3 Europe AI in Pathology Market, by End User
1.4.4 Europe AI in Pathology Market, by Component
1.4.5 Europe AI in Pathology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 Market Share Analysis, 2022
4.2 Recent Strategies Deployed in AI in Pathology Market
4.3 Porter’s Five Forces Analysis
Chapter 5. Europe AI in Pathology Market, By Neural Network
5.1 Europe Convolutional neural networks (CNNs) Market, By Country
5.2 Europe Generative adversarial networks (GANs) Market, By Country
5.3 Europe Recurrent neural networks (RNNs) Market, By Country
5.4 Europe Others Market, By Country
Chapter 6. Europe AI in Pathology Market, By Application
6.1 Europe Drug Discovery Market, By Country
6.2 Europe Disease Diagnosis & Prognosis Market, By Country
6.3 Europe Clinical Workflow Market, By Country
6.4 Europe Others Market, By Country
Chapter 7. Europe AI in Pathology Market, By End User
7.1 Europe Pharmaceutical & Biotechnology Companies Market, By Country
7.2 Europe Hospitals & Reference Laboratories Market, By Country
7.3 Europe Academic & Research Institutes Market, By Country
Chapter 8. Europe AI in Pathology Market, By Component
8.1 Europe Scanners Market, By Country
8.2 Europe Software Market, By Country
Chapter 9. Europe AI in Pathology Market, By Country
9.1 Germany AI in Pathology Market
9.1.1 Germany AI in Pathology Market, By Neural Network
9.1.2 Germany AI in Pathology Market, By Application
9.1.3 Germany AI in Pathology Market, By End User
9.1.4 Germany AI in Pathology Market, By Component
9.2 UK AI in Pathology Market
9.2.1 UK AI in Pathology Market, By Neural Network
9.2.2 UK AI in Pathology Market, By Application
9.2.3 UK AI in Pathology Market, By End User
9.2.4 UK AI in Pathology Market, By Component
9.3 France AI in Pathology Market
9.3.1 France AI in Pathology Market, By Neural Network
9.3.2 France AI in Pathology Market, By Application
9.3.3 France AI in Pathology Market, By End User
9.3.4 France AI in Pathology Market, By Component
9.4 Russia AI in Pathology Market
9.4.1 Russia AI in Pathology Market, By Neural Network
9.4.2 Russia AI in Pathology Market, By Application
9.4.3 Russia AI in Pathology Market, By End User
9.4.4 Russia AI in Pathology Market, By Component
9.5 Spain AI in Pathology Market
9.5.1 Spain AI in Pathology Market, By Neural Network
9.5.2 Spain AI in Pathology Market, By Application
9.5.3 Spain AI in Pathology Market, By End User
9.5.4 Spain AI in Pathology Market, By Component
9.6 Italy AI in Pathology Market
9.6.1 Italy AI in Pathology Market, By Neural Network
9.6.2 Italy AI in Pathology Market, By Application
9.6.3 Italy AI in Pathology Market, By End User
9.6.4 Italy AI in Pathology Market, By Component
9.7 Rest of Europe AI in Pathology Market
9.7.1 Rest of Europe AI in Pathology Market, By Neural Network
9.7.2 Rest of Europe AI in Pathology Market, By Application
9.7.3 Rest of Europe AI in Pathology Market, By End User
9.7.4 Rest of Europe AI in Pathology Market, By Component
Chapter 10. Company Profiles
10.1 Koninklijke Philips N.V.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.6 SWOT Analysis
10.3 Hologic, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Visiopharm A/S
10.4.1 Company Overview
10.4.2 Recent strategies and developments:
10.4.2.1 Partnerships, Collaborations, and Agreements:
10.4.3 SWOT Analysis
10.5 Paige AI, Inc.
10.5.1 Company Overview
10.5.2 Recent strategies and developments:
10.5.2.1 Partnerships, Collaborations, and Agreements:
10.5.2.2 Product Launches and Product Expansions:
10.5.3 SWOT Analysis
10.6 PathAI, Inc.
10.6.1 Company Overview
10.6.2 Recent strategies and developments:
10.6.2.1 Partnerships, Collaborations, and Agreements:
10.6.3 SWOT Analysis
10.7 Aiforia Technologies Plc
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Recent strategies and developments:
10.7.3.1 Partnerships, Collaborations, and Agreements:
10.7.4 SWOT Analysis
10.8 Indica Labs, Inc.
10.8.1 Company Overview
10.8.2 Recent strategies and developments:
10.8.2.1 Partnerships, Collaborations, and Agreements:
10.8.3 SWOT Analysis
10.9 Optrascan, Inc. (Optra Ventures, LLC)
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
10.9.2.2 Product Launches and Product Expansions:
10.9.3 SWOT Analysis
10.10. MindPeak GmbH
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Partnerships, Collaborations, and Agreements:
10.10.3 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us